Merit Medical Systems | MMSI - Selling And Administration Expenses

Stock Price
68.54
Daily Change
-0.07 -0.10%
Monthly
0.63%
Yearly
-27.56%
Q2 Forecast
69.37

Merit Medical Systems reported $114.83M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
3M USD 744M 221M Mar/2026
Abbott USD 3.27B 138M Mar/2026
AngioDynamics USD 36.57M 3.79M Sep/2025
Anika Therapeutics USD 10.01M 14K Dec/2025
AtriCure USD 78.34M 109K Dec/2025
Baxter International USD 761M 53M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
Cooper Companies USD 373.1M 46.1M Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
Edwards Lifesciences USD 522.2M 80.7M Mar/2026
Globus Medical USD 318.48M 4.88M Dec/2025
Haemonetics USD 109.15M 7.54M Dec/2025
ICU Medical USD 155.81M 3.04M Dec/2025
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
J&J USD 6.03B 719M Mar/2026
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 114.83M 7.45M Dec/2025
Olympus JPY 125.65B 5.75B Dec/2025
Pfizer USD 4.08B 894M Dec/2025
STAAR Surgical USD 38.94M 20.44M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Surmodics USD 11.4M 3.18M Jun/2025
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 222.37M 59.4M Dec/2025
Terumo JPY 105.26B 7.38B Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025